1. INTRODUCTION
A manufacturer of a medical device must demonstrate that the intended purpose(s) and claim(s)
made in relation to safety and performance of a Medical Device are achieved, as referred to in the
Medical Device Directives. As a general rule, such demonstration will require clinical data. Clinical
data is data which is relevant to the various aspects of the clinical safety and performance of the
device. This may include data from prospective and retrospective clinical investigations of the
device concerned as well as market experience of the same or equivalent devices and medical
procedures and information from the scientific literature. Clinical evaluation is based on the
assessment of the risks and the benefits, associated with the use of the device, through either a
compilation of relevant scientific literature or the results of a clinical investigation or both of these.
Orthofix Srl has determined that in order to fulfil the above essential requirements of the Medical
Device Directive it is necessary to conduct a Clinical Evaluation to determine whether or not
sufficient clinical data exists to demonstrate the necessary safety and performance criteria for the
Orthofix Oscar Ultrasonic Arthroplasty Revision Instrument device.
This Clinical Evaluation Report is prepared according to the European Guideline MEDDEV
2.7/1 Rev. 4, and it updates and replaces previous reports.
2. DEVICE DESCRIPTION
This paragraph has been prepared on the basis of the information provided in the device IFU
Version PQ OSC B 02/17, Operative Technique Version OS-1501-OPT-E0 B 01/16, and commercial
brochure Version OS-1601-PL-E0 A 12/16. These documents are available in Annex B.
The Orthofix Oscar Ultrasonic Arthroplasty Revision Instrument is an ultrasonic device that is
applied in Orthopaedics to facilitate bone cement removal during arthroplasty revision surgeries
and to perform bone osteotomies when needed. Hereafter, we will simply refer to the device as
Oscar.
The OSCAR system is comprised of a portable generator which has 2 output channels. Both output
channels drive cement removal or osteotome handsets. A large range of cement removal and
osteotome probes are available. Depending on the application, some probes are single-use, and
provided sterile, while other are reusable and provided non-sterile.
The operating principles are as follows: the generator supplies a high frequency alternate signal to
the piezoelectric stack transducer in the handset. This makes the probe resonate at an ultrasonic (>
16kHz) frequency. When the probe is placed adjacent to bone cement it causes it to melt. When
the probe is placed adjacent to bone, it cuts it.
The device is an active, non-implantable, surgically invasive device as it penetrates inside the body
through the surface of the body in the context of a surgical operation. The duration of use/contact
with the body is transient (less than 60 minutes). The device gets in contact with the patient’s bone
tissue, and with the patient’s blood.
Regulatory class: IIb (93/42/EEC Directive as amended, Annex IX, Rule 9, first
paragraph)
Materials:
Single use/reusable: Some probes are reusable while others are single-use.
Conditions of use: All Orthofix devices are intended for professional use only. Surgeons
who supervise the use of Orthofix devices must have full awareness
of orthopaedic and, specifically, of arthroplasty revision procedures.
Contraindications: Generally, the use of the device is contraindicated when the above
surgical operations are contraindicated. No other specific
contraindication to the use of the device exists. Yet, as no clinical
evaluation is available, Orthofix is unable to confirm the safety of use
of the OSCAR where a patient or an operator of the unit has been
fitted with a cardiac pacemaker. It is, therefore, left to the clinician’s
discretion as to the use of the OSCAR in this situation. However, no
adverse effects have been reported so far.
The device does not incorporate any medicinal substance, animal tissue or derivative or blood
component.
Orthofix is aware of the following CE-marked devices with the same intended use (bone cutting
and/or bone cement removal): Biomet Ultra-Drive 3, Mectron Piezosurgery Medical/Flex/Plus,
Misonix Ultrasonic BoneScalpel.
There are medical alternatives to the use of piezoelectric devices. Bone tissue cutting can be
performed through numerous means; from manual instruments, such as scalpels, hammers and
saws, to motorized tools, to laser and ultrasounds. Cement removal can also be performed using
various instruments, including conventional manual cement removal tools such as drills, burs,
curettes, and flexible osteotomes or motors driven tools, such as drills, burrs, and saws. For more
details, please refer to Section 4.
The Oscar device is CE-marked and is currently on the market in Europe and in Chile, Honk Kong,
Israel, Libya, Lebanon, Oman, Qatar, South Africa, Switzerland, United Kingdom.
It is registered also in Australia, New Zealand, USA, Puerto Rico, Saudi Arabia.
The Orthofix Oscar Ultrasonic Arthroplasty Revision Instrument is intended to be used for cutting
and removal of bone and acrylic bone cement in orthopaedic applications.
The target treatment group are those patients undergoing arthroplasty revisions and patients
undergoing orthopaedic surgical operations calling for an osteotomy to be performed.
Generally, the use of the device is contraindicated when the above surgical operations are
contraindicated. No other specific contraindication to the use of the device exists. Yet, as no clinical
evaluation is available, Orthofix is unable to confirm the safety of use of the OSCAR where a
patient or an operator of the unit has been fitted with a cardiac pacemaker. It is, therefore, left to
the clinician’s discretion as to the use of the OSCAR in this situation. However, no adverse effects
have been reported. This information is made available to the user in the device IFU.
The OSCAR 3 device is intended to be used by surgeons trained in standard orthopaedic surgical
procedures and specifically trained in the use of ultrasonic surgical instruments.
• Handle the acoustics (handset and probes) with care. Do not attempt to modify the acoustics.
Damage or changes can affect the ability to attain resonance and reduce the effectiveness of the
device. Do not use if damage is suspected.
• Sparks may be produced if the probes touch anything metal while activated. This equipment is
not to be used in the presence of flammable gases or liquids.
• Use only genuine OSCAR accessories to assure compatibility and compliance with the
requirements of 60601-1-2 in terms of emissions and immunity.
• The use of unofficial accessories (Handsets and cables), which are not OSCAR original
components may increase emission or decrease immunity of the OSCAR System.
• This device should only be used by qualified surgeons who are (1) suitably trained in the
arthroplasty revision surgery procedures that are to be carried out and (2) trained in the specific
use of ultrasonic surgical instruments intended for use during arthroplasty revision.
• OSCAR system must not be used adjacent to or stacked with other equipment.
• The probes may become hot during use. Do not allow the probes to contact tissue following
use.
• Do not allow the probes to contact tissue between activations, in case accidental activation
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
should occur. Tel 045 6719000 Fax 045 6719380
• Care should be taken when operating in the vicinity of nerves.
• To avoid the risk of electric shock, thisPage 4 of 100 must only be connected to a grounded
equipment
power supply.
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Warnings - In Use
• Do not operate OSCAR in the presence of flammable gases or liquids and an environment rich
with oxygen.
• Single use probes should not be reprocessed under any circumstances.
• As no clinical evaluation is available, Orthofix SRL is unable to confirm the safety of use of the
OSCAR where a patient or an operator of the unit has been fitted with a cardiac pacemaker. It
is, therefore, left to the clinician’s discretion as to the use of the OSCAR in this situation.
However, no adverse effects have been reported.
• Please take care of the handsets, probes and cables as rough treatment may affect the safety
and performance of the unit.
• The use of handsets or probes not supplied as part of the OSCAR system may damage the
generator and create a safety hazard for the operator and patient.
• Avoid allowing an energised probe to come into contact with any metal surface.
• Avoid touching or holding the probes when the handset is energised.
• The generator may be shutdown (disconnected) by use of the switch on the rear panel.
• Where possible, avoid allowing probes to become stuck in cement as this may cause the
generator thermal trip to operate. However, if this situation occurs refer to section Problems
and Solutions: Removal of probe stuck in cement.
• Do not allow an energised probe to come into firm contact with skin or muscle, as this will
cause a friction burn. Skin should be protected with a dry swab.
• Do not over tighten the probes to the handsets.
• The use of accessories, transducers and cables other than those specified, with the exception
of transducers and cables sold by Orthofix SRL as replacement parts for OSCAR may result in
increased emissions or decreased immunity.
• Servicing and maintenance activities shall be conducted in the absence of a patient.
• OSCAR should not be used adjacent to or stacked with other equipment. If adjacent or
stacked use is necessary OSCAR should be observed to verify normal operation in the
configuration in which it will be used.
• To avoid the risk of electric shock, this equipment must only be connected to a grounded
power supply.
• Mains Isolation is achieved by use of the double pole switch located on the rear panel.
• No modification of this equipment is required.
• Do not use OSCAR simultaneously with laser equipment or high frequency surgical
equipment. Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 5 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
For instructions on how to handle Scratches on Probes, Damage or Wear on Piercer and Scraper
Cutting Heads, Damage or Wear on Cables please refer to IFU Version PQ OSC B 02/17 (Annex B).
Cleansing and Sterilising procedures (before and after use) are described in detail in IFU Version
PQ OSC B 02/17 (Annex B).
The instructions for irrigation, and its importance, are stated in the device IFU as follows below.
Irrigation of the bone canal following a period of cement removal is important for two reasons.
Firstly, it clears the canal of cement debris and secondly it maintains safe operating
temperatures. It is recommended that irrigation, in the form of pulsed lavage or manual
irrigation, is used intermittently following use of the scrapers or groover probes and that the
frequency of irrigation is more frequent when using the piercer probes.
Do not irrigate during ultrasonic energy application, this will compromise the speed of removal
and efficacy of transmission. The design of the OSCAR probes is specifically aimed at achieving
rapid heating and transference of the softened cement. Cooling during an energy cycle will
delay this action and reduce the energy available.
Notes: If possible chilled saline should be used Refer to video material of OSCAR use
It is important to maintain a steady flow of saline around the prosthetic stem during insertion of
the flat osteotomes, particularly when cutting cortical bone. This helps to keep the metal on
metal interface cool and lubricated whilst the active edges of the osteotome are cutting bone.
• Bibliographic Search 1
Term 1 Term 2 Time limit
revision arthroplasty bone cutting 01/01/2007-30/6/2017
revision surgery bone removal
orthopaedic acrylic bone cement
orthopedic
orthopaedics
orthopedics
This search produced 841 literature records; of those, 376 references were single records (not
duplicates).
• Bibliographic Search 2
Term 1 Term 2 Time limit
ultrasound bone cutting 01/01/2007-30/6/2017
piezoelectric bone removal
Oscar 3 acrylic bone cement
Oscar III revision arthroplasty
ultrasonic bone cement removal
arthroplasty revision
This search produced 508 literature records; of those, 203 references were single records (not
duplicates).
• Bibliographic Search 3
Term Time limit
bone cutting 01/01/2007-30/6/2017
bone cement removal
This search produced 148 literature records; no duplicates were retrieved within the search.
The literature records were screened to exclude duplicate references (within the same
bibliographic search or between different searches), articles written in a language other than
English, articles not dealing with the topic of interest, articles that were not reviews.
At the end of the screening process, 11 references were deemed as useful to provide
information regarding the clinical background on the use of piezoelectric devices for bone cutting
or bone cement removal. References that were cited in these reviews and were considered
relevant to the state of the art were also included in the analysis of the clinical background. One
reference (Jasper at al., 2016) was retrieved through an independent PubMed search.
In conclusion, 35 references were included in the state of the art; the list of the references
is provided at the end of this section, and in Annex F. Full-texts are available in Annex B.
The piezoelectric effect was first described in 1880 by Jacques and Pierre Curie, when they
discovered that applying pressure on certain polarized materials creates electricity. First ultrasonic
devices were originally developed for dentistry for cavity preparation of human teeth. Then, Dr.
Richman introduced the first ultrasonic chisel for bone removing during apicoectomies and in 1960
Mazzarow’s equip used an ultrasonic scalpel-like blade for bone cutting. Since then, they were
quickly adapted, and their use was expanded to other medicine fields.
Piezoelectric devices usually consist of a hand-piece, a foot switch and a power unit. A
peristaltic pump jets an irrigation fluid, normally saline, that removes debris from the cutting area
inducing a cavitation effect that helps to maintain good visibility in the operative field by
dispersing the fluid as an aerosol that keeps the area of the irrigation blood-free. The flow is
adjustable (0-60 ml/min) and it is refrigerated at 4°C for cooling the surgery area (Thomas et al.,
2017). A frequency of 25–29 kHz is used to cut only mineralized tissue such as bones while soft
tissue cutting happens in the range of 50 kHz (Labanca et al, 2008). The power unit may have
three different power levels: low mode for orthodontic surgery, high mode for cleaning, and a
boosted mode for osteotomy and osteoplasty. There is a range of inserts (tips) available, which
can vary in size, shape and material depending on the surgery purpose. There are extensive
indications of piezo surgery in dental implantology and oral and maxillofacial bone surgery,
however in literature other surgical disciplines such as craniofacial surgery, plastic and
Bone cutting
In surgical operations bone surgery interventions consist of a combination of performing cutting
action (osteotomy) and remodeling (osteoplastic procedures) of the bone surface.
Critical points in osteotomy are: to achieve a high accuracy and precision in bone cutting together
with safety and rapidity of the recovery.
Bone tissue cutting can be performed through numerous means; from manual and
motorized tools, to laser and ultrasounds. Manual and motorized instruments are considered the
traditional tools for bone surgery. Manual techniques, such as scalpels, hammers and saws,
depend to the mechanical force exerted by the surgeon, therefore they may have a good cutting
efficacy, but not easily controllable. In motor-driven instruments the cutting capacity is related to
electric energy and mechanical force; the cutting is, therefore, the result of rotation produced by
the movement of a drill or by the oscillating movement of a saw plus the pressure exerted on the
handle (Marco et al., 2014). Therefore, drilling process may result in frictional heat and thermal
necrosis, damaging the edge of the bone surrounding the drilled hole where the fixation screw will
be located and leading to osteonecrosis. Drilling is extensively used in orthopedics, traumatology
and dentistry. Bone grinding is often used for plane bones, such as the skull base, in neurosurgery
together with endoscopic technologies. Bone milling is used in surgery where an accurate
machining of the bone surface is required, for instance in the total knee arthroplasty. Under
various cutting conditions this tool can reach 49°C to 115°C, and the thermal damage may reach
about 2 mm in depth. Eriksson et al. showed that local bone necrosis would occur when the
temperature exceeds 47°C for 1 minute (Eriksson et al., 1984). Conventional osteotomies need a
constant physical pressure of the hand piece on the bone surface to increase the effectiveness of
the cut, limiting the precision and the sensitivity. Therefore, it is difficult to determine the cutting
depth. For instance, during an osteotomy of more mineralized bones the high pressure exerted
suddenly becomes excessive when the cortical bone is finished, causing an immediate loss of
control of the surgical tool, a condition that can become very dangerous in close proximity of
delicate anatomical structures, such as nerves and vessels. Thus, the surgical sensitivity and the
control of the tool are reduced when there are structures presenting different mineralization
(Yaman and Suer, 2013). Indeed, the injury caused to surrounding living tissues or neurovascular
system can lead to detrimental outcome for the patient and decelerate wound healing. Also, all
these tools reach an excessive temperature inducing thermal necrosis in the tissue surrounding
the cutting zone and in the bone itself impairing bone regeneration.
Several parameters are involved in heat generation during cutting, such as the type of
approach, the structure and density of the bone tissue and the cutting force exerted on the handle
(Marco et al., 2014). Furthermore, traditional motorized instruments, especially the saw, generate
The development of piezoelectric techniques was driven by the urge to get greater precision and
safety in bone surgery than with manual and motorized surgical tools. As described in the first
section, the principle of piezosurgery is ultrasonic transduction, obtained by piezoelectric ceramics
or crystals contraction and expansion. The vibrations are amplified and transferred into the insert
tip which, when applied rapidly with slight pressure and in the presence of irrigation with
physiological solution, results in the cavitation phenomenon, with a mechanical cutting effect,
exclusively on mineralized tissue.
Over the past two decades, a large amount of literature has showed benefit using
piezosurgery method and there is a wide range of methods now in use and applied in several
surgery’s fields, such as dental implantology, oral and maxillofacial surgery, craniofacial surgery,
plastic and reconstructive surgery, head and neck surgery, neurosurgery, ophthalmology,
traumatology, orthopedics, hand surgery and pediatric surgery (Labanca et al., 2008; Yaman and
Suer, 2013). Piezosurgery was introduced as a technique that would further reduce the major risks
in osteotomy (bleeding, osteonecrosis and damage to soft tissue).
As mentioned above, piezoelectric devices usually consist of a hand-piece and foot switch
and a power unit. Then, a peristaltic pump jets a refrigerated irrigation fluid inducing a cavitation
effect that helps to maintain good visibility in the operative field and to cool down the surgery
area (Thomas et al., 2017). A frequency of 25–29 kHz is used for bone cutting. The insert tips
available have linear vibration ranging from 60 to 200 µm and can be classified in: (i) sharp insert
tip, for osteoplasty techniques or for harvesting bone chips; (ii) smooth insert tip, for precise and
controlled work on bone structure and (iii) blunt insert tips, for preparing soft tissue (for example
for preparing root planning in periodontics) (Thomas et al., 2017). The most effective way to use
the hand piece is with high speed and low pressure because increasing the working pressure
causes its vibration to cease.
The technique of piezoelectric surgery is three times more powerful than normal ultrasound,
therefore can cut highly mineralized bone, and offers several advantages over traditional manual
or power-driven methods (Robiony et al., 2004).
The frequency of 25-29 kHz allows highly precise cutting due to its micrometric and linear
vibrations with absolute confidence, particularly in close proximity to vessels, nerves, dura matters
and mucosa. The controlled motion of the device probe results in a neater and precise cut due to
the absence of macrovibrations. Indeed, the piezoelectric drill is the result of linear microvibration
with a range of only 20-60 ƞm in a longitudinal direction (Crosetti et al., 2009). In this way, a more
effective and safe osteotomy is achieved compared to traditional rotating or hand tools, also
thanks to a lesser surgeon’s strength required to make cuts. This modulated frequency of the
vibration produces an efficient cutting action on the bone of different mineralization without
leaving osseous fragments at the edge of the cut, that have been demonstrated to be the main
cause of overheating produced by normal ultrasound (Crosetti et al., 2009).
Another piezosurgery characteristic is its high specificity for mineralized tissues whilst
minimizing trauma to surrounding soft tissue. Indeed, differently from bone tissue, neurovascular
tissue and other soft tissues are cut with frequencies higher than 50kHz (Labanca et al., 2008).
Adapting the ultrasound frequency allows safe cutting of hard tissue and avoid any soft tissue
damage; adjacent soft tissue and nerve remain safe due to the cessation of the surgical action
when the insert tip meets non-mineralized tissues.
Regarding surrounding tissue damage with piezosurgery, Schaeren and co-workers
investigated the potential damage of piezosurgery to a peripheral nerve on direct contact in two
possible scenarios, using a rat model. The first one represents the worst-case scenario, in which
the surgeon does not immediately realize the contact with a nerve and continues to operate for 5
seconds; the second scenario corresponds to an accidental slip of the device on the bone tissue
(they estimated a higher force but for a shorter time, 1 second). They monitored the nerve
function from the first day after the surgery up to 150 days after injury. They concluded that even
in the worst-case scenario the perineurium of the nerve remained intact and the nerve was not
dissected, thus enhancing the potential for functional recovery (Schaeren et al., 2008). These
results are also in agreement with the finding of other studies; one study compared the use of
piezoelectric devices with conventional tools on soft and hard tissue for transposition of the
inferior alveolar nerve in sheep; another study assessed the neurosensory damage of the inferior
lip and chin after bilateral sagittal spit osteotomy in 20 patients. Both studies reported less
damage to soft tissue, particularly neurovascular tissue when using a piezoelectric device than
conventional methods (Labanca et al., 2008).
Cavitation effect, created by the interaction between the jet irrigation with physiological
saline solution and the oscillating insert tips keeps the surgical site clean from debris and blood
maintaining a better visualization in the operation field. Furthermore, it has been suggested that
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 14 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
On the other hand, few limitations of piezosurgery have been reported. A proper surgeon
training is necessary since the surgical handling required is completely different from that used
with drills and saws and it is important to use the correct pressure to achieve the desired results.
Pressure of the hand should not be increased (as with drills or saws), since, above certain limits, an
increase in pressure prevents the microvibration of the insert: the energy not used for cutting the
mineralized structures is dispersed as heat leading to necrosis of the bone itself and the
surrounding soft tissues. Indeed, in the case of an eventual contact with soft tissue, the procedure
should be immediately interrupted, in order to avoid unnecessary heat on the soft tissue (Crosetti
et al., 2009).
To now, the lack of insert of appropriate length and thickness makes difficult deeper osteotomies
(Thomas et al., 2017).
A slightly longer operating time compared to traditional methods is needed (Thomas et al., 2017).
However, in some surgery’s fields, such as craniotomy, where the surgeon spends time in
preserving soft tissues and the dura mater from damage and in controlling bleeding from
craniotomy’s borders, the overall surgical procedure duration is not significantly longer compared
to traditional techniques (Iacoangeli et al., 2017)
After more than 50 years from its introduction, bone cement is still the only material used
for prosthesis fixation. In vertebroplasty PMMA is used to treat vertebral fractures; it is injected
into the vertebrae usually through the vertebral pedicles or, during the execution of kyphoplasty,
to fill the cavity produced by an inflated balloon pushed inside the vertebrae to lift the fractured
and depressed vertebral body. Bone cements can function as a matrix for the local application of
antibiotics. Supplementing the bone acrylic cement with additives, such as powders of antibiotics
like gentamicin, function as drug delivery system especially in case of infection (infection as an
incidence between 0.5 and 3 % in primary hip and knee prosthesis and a higher incidence in the
case of revision procedure) when prosthetic implant integrity declines overtime up to the point in
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 19 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
In hip prosthesis, femoral stem extraction is challenging. A study of 1398 femoral revisions
showed intraoperative fractures in 12% and cortex perforation in 5% of cases. (Laffosse et al.,
2016). In general the stem of the prosthetic implant is easily removed, particularly if it has a
smooth surface. The main challenge resides in removing the cement and plug during which several
complications may arise including perforations, fractures, and incomplete cement removal
responsible for further bone damages that may compromise the implantation of the new femoral
component (Laffosse et al., 2016). Removal of cemented prosthesis needs a thorough and efficient
disposal of the cement material used. Cement removal can be performed using various
instruments, usually chisels and drills, curettes or motors driven tools characterized by a very high
rotational speed. However, these methods are time consuming and technically difficult, with high
risk of bone perforation and bone loss. Another method for removing old cement consists in the
Segmental Cement Extraction System. With this method, a threaded rod is cemented into the
cement mantle; all the components of the system and the cement are then extracted as a single
unit tapping gently to a slap hammer attached to the rod (Ekelund et al., 1992). Mechanical
cement removal techniques have high incidence of complication due to perforation and fracture
reported as high as 13%.
Ultrasound application can be used for cement removal; the energy generated by the
instrument’s tip heats the cement, thereby causing it to disintegrate. Considerably lower incidence
of bone damage is found when ultrasound is employed. Three separate studies reported the
following cortical perforation rates: 3 out of 90 cases by one study, none out of 20 in the second
and 1 in 48 from revision hip arthroplasties (Goldberg et al, 2008).
After a cemented primary fixation, thorough removal of old cement is essential for femoral
revision but it might lead to further bone loss and consequently inadequate fixation of the
subsequent revision stem. Femoral impaction allografting has been widely used in revision surgery
for the acetabulum, and subsequently for the femur. Impacted morsellized bone graft are
incorporated by the host skeleton therefore creating a new endosteal surface. Impaction grafting
might technically be more challenging and time consuming than cementless fixation techniques,
however it enables a reliable restoration of bone stock especially important if further revision is
planned (Gehrke et al., 2013).
References
Boileau P, Avidor C, Krishnan SG. Cemented polyethylene versus uncemented metal-backed
glenoid components in total shoulder arthroplasty: a prospective, double-blind, randomized
study. J Shoulder Elbow Surg. 2002; 11: 351–359.
Brooks AT, Nelson CL, Hofmann OE. Minimal femoral cortical thickness necessary to prevent
perforation by ultrasonic tools in joint revision surgery. J Arthroplasty. 1995; 10:359-362
Chaichana KL, Jallo GI, Dorafshar AH, Ahn ES. Novel use of a n ultrasonic bone-cutting device
for endoscopic-assisted craniosynostosis surgery. Chids Nerv Syst. 2013.
Corten K., Bourne R.B., Charron K.D., Au K., Rorabeck C.H. What works best, a cemented or a
cementless primary total hip arthroplasty? Minimum 17- follow up over randomized controlled
trial. Clin Orthop Relat Res. 2011;469:209-17
Crosetti E., Battiston B., Succo G. Piezosurgery in head and neck oncological and reconstructive
surgery:personal experience on 127 cases. Acta Otorhinolaryngol Ital. 2009;29:1-9.
Douglas L. Miller, Nadine B. Smith, Michael R. Bailey, Gregory J. Czarnota, Kullervo Hynynen,
Inder Raj S. Makin. Overview of Therapeutic Ultrasound Applications and Safety
Considerations. J Ultrasound Med. 2012;31:623-634.
Ekelund A.L. Cement removal in revision hip arthroplasty. Experience with bone cement added
to the cavity in 20 cases. Acta Orthop Scand. 1992; 63: 549-551.
Etayeb A.S., Ahmad A.G. Piezosurgery: A safe technique for inferior alveolar nerve mobilization
in surgical correction of hemimandibular hyperplasia-Review of the literature and case report.
In J of Surgery Case Reports. 2016.
Eriksson AR, Albrektsson T, Albrektsson B. Heat caused by drilling cortical bone. Temperature
measured in vivo in patients and animals. ActaOrthop Scand. 1984;55:629-31.
Gardiner R, Hozack WJ, Nelson C, Keating EM. Revision total hip arthroplasty using
ultrasonically driven tools. A clinical evaluation. J Arthroplasty. 1993;8:517-21.
Goldberg SH, Studders EM, Cohen MS. Ultrasonic cement removal in revision arthroplasty.
Orthopedics. 2007;30:632-5
Iacoangeli M., Neri P., Balercia P., Lupi e., Di Rienzo A., Nocchi N., Alvaro L., Scerrati M.
Piezosurgery for osteotomies in orbital surgery: our experience and review of the literature. In
J of Surgery Case Report. 2013: 188-191.
Jasper L.L., C. A. Jones, J. Mollins, S. L. Pohar and L. A. Beaupre. Risk factors for revision of total
knee arthroplasty: a scoping review. BMC Musculoskeletal Disorders. 2016;17:182.
Klapper RC, Caillouette JT, Callaghan JJ, Hozack WJ. Ultrasonic technology in revision joint
arthroplasty. Clin Orthop Relat Res. 1992;285:147-54.
Kreder HJ, Grosso P, Williams JI, Jaglal S, Axcell T, Wai EK, et al. Provider volume and other
predictors of outcome after total knee arthroplasty: a population study in Ontario. Can J Surg.
2003;46:15–22.
Labanca M, Azzola F, Vinci R, Rodella LF. Piezoelectric surgery: twenty years of use. Br J Oral,
2008.
Laffosse JM. Removal of well-fixed fixed femoral stems. Orthop Traumatol Surg Res.
2016;102(1 Suppl):S177-87.
Magnan B, Bondi M, Maluta T, Samaila E, Schirru L, Dall’Oca C. Acrylic bone cement: current
concept review. Musculoskelet Surg. 2013;97:93–100.
Meneghini RM, de Beaubien BC. Early failure of cementless porous tantalum monoblock tibial
components. J Arthroplasty. 2013;28:1505–1508
Park JW, Kim YH. Simultaneous cemented and cementless total knee replacement in the same
patients: a prospective comparison of long-term outcomes using an identical design of NexGen
prosthesis. J Bone Joint Surg Br. 2011;93:1479–1486.
Robiony M, Polini F, Costa F, Zerman N, Politi M. Ultrasonic bone cutting for surgically assisted
rapid maxillary expansion (SARME) under local anaesthesia. Int J Oral Maxillofac Surg
2007b;36:267-9.
Salami A., Dellepiane M., Crippa B., Mora R., A new method for osteotomies in oncologic nasal
surgery: Piezosurgery. American journal of Otolaryngology-Head and nack medicine and
surgery 2010.
Saleh KJ, El Othmani MM, Tzeng TH, Mihalko WM, Chambers MC, Grupp TM. Acrylic bone
cement in total joint arthroplasty: A review. J Orthop Res. 2016;34:737-44.
Schaller BJ, Gruber R, Merten HA, Kruschat T, Schliephake H, Buchfelder M, Ludwig HC.
Piezoelectric Bone Surgery: A Revolutionary Technique for Minimally Invasive Surgery in
Cranial Base and Spinal Surgery? Technical Note. Neurosurgery. 2005; 57(4 Suppl):E410.
Spinelli G, Mannelli G, Zhang YX, Lazzeri D, Spacca B, Genitori L, Raffaini M, Agostini T. Complex
craniofacial advancement in pediatric patients: piezoelectric and traditional technique
evaluation. J of Crani-Maxillo-facial surgery. 2015;43:1422-7.
Thomas M, Akula U, Ealla KK, Gajjada N. Piezosurgery: A Boon for Modern Periodontics. J Int
Soc Prev Community Dent. 2017;7:1-7.
Wiater JM, Moravek JE, Jr., Budge MD, et al. Clinical and radiographic results of cementless
reverse total shoulder arthroplasty: a comparative study with 2 to 5 years of follow-up. J
Shoulder Elbow Surg. 2014;23:1208–1214.
Yaman Z. and Suer B.T. Piezoelectric surgery in oral and maxillofacial surgery. Annals of oral &
maxillofacial surgery. 2013;1:5.
b) if the Oscar device actually provides the intended performance and the intended clinical
benefits.
This Clinical Evaluation was performed through a compilation of relevant published scientific
literature and subsequent critical evaluation of this compilation (literature route). Literature
include clinical data on the device concerned and on equivalent devices already on the market.
Analysis of equivalence between the Oscar device and the equivalent devices was therefore
requested.
Details about the assessment of equivalence, and its justification, are provided in Section 8 and in
the Literature Search Report (Annex B). Technical details about these devices are provided as an
attachment (see Annex B).
Data assessed were only those describing the clinical applications of devices equivalent to the
Oscar device and the consequent outcomes in term of performance and safety. Criteria applied to
perform the literature search to identify this kind of data only (i.e., clinical data) are provided in the
Clinical Evaluation Plan (Annex A).
This Clinical Evaluation was conducted according to a well-defined and methodological procedure
detailed in the Clinical Evaluation Plan (Annex A).
In summary:
The Clinical Evaluation Plan was prepared before performing any literature search. It describes how
the literature search was planned.
- Evaluation of equivalence: The evaluation of equivalence between the Oscar device and a
candidate equivalent device was performed by comparing the key characteristics of the two
devices, with the aid of a Product Comparison Form. Characteristics subjected to comparison were
a) Clinical; b) Technical; c) Biological. The following clinical characteristics were compared: 1) the
clinical condition/purpose/indication; 2) the site of application to/in the body; 3) the patient
population. Technical characteristics undergoing comparison were 1) the conditions of use; 2) the
device specifications and properties; 3) the device design; 4) the principles of the device operative
technique. As far as the biological characteristics were compared, an analysis of the materials of
the two devices in contact with the same body fluids/tissues was carried out.
- Identification of appropriate data and documents (search strategy): the literature search was
performed searching the PubMed database. The PubMed database was selected because it collects
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 31 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
1) Identify and retrieve papers detailing clinical investigation (i.e. investigations on human
subjects) whose aim was specifically to assess the effectiveness and safety of the Oscar/an
equivalent device.
2) Identify and retrieve papers detailing clinical investigations (i.e. investigations on human
subjects) with different aims than above, but testifying about the use of the Oscar/an equivalent
device.
3) Identify and retrieve papers detailing cadaver investigations aimed to assess the safety of
the Oscar/an equivalent device.
a) Concerning aim no. 1), the PubMed database was searched for a list of 71 search strings.
Details of each search are provided in the Literature Search Report (Annex B).
This search was limited to papers published from 1992 onward, as one of the equivalent devices
was first placed on the market in 1992 (Oscar was first placed on the market in 1996).
- additionally, the websites of the manufacturers of the equivalent devices were visited to
collect information about the existence of publications of interests. If useful information was
present, (for example, as the complete paper or as a list of publications), the publications were
either downloaded from the manufacturer’s website or searched for in the PubMed database.
- additionally, a heuristic search was performed for further publications: as papers were
found according to the selection criteria for evaluation, a further search was performed to assess if
their authors, while working at the same clinical/research facility, published further papers
describing the use of the Oscar device or of the equivalent/substantially equivalent devices. This
search was performed under the rationale that those authors had the devices of interest available
at their centers, and could have used them for further studies.
Inclusion/exclusion criteria
Literature which met the following criteria was excluded from review:
- pertaining to fields other than Orthopedics, Hand&Foot Surgery, Neurosurgery
- reviews, notes, editorials with no clinical data
- retrospective analyses of literature data
- retrospective analyses of national registers
- written in languages other than English
- concerning in vitro or animal studies
- concerning non-equivalent devices
Only data which were not excluded and met the following criteria were selected for review:
- The data must relate to the specific characteristics and features of the device
- The data must relate to the same clinical condition or purpose of the device, yet in deviation to
this rule, and concerning the “bone cutting” intended use only, paper detailing the use of devices
equivalent to Oscar for bone cutting in area different than Orthopedics, and specifically
Neurosurgery, ENT, Hand&Foot Surgery were considered as well. Proper justification is provided in
Annex A – Clinical Evaluation Plan. Cadaver studies were considered too as detailed in c).
- The data should be related to use at the same site in the body of the device. Again, in deviation to
this rule, and concerning the “bone cutting” intended use only, paper detailing the use of devices
equivalent to Oscar for bone cutting in area different than Orthopedics, and specifically
Neurosurgery, ENT, Hand&Foot Surgery were considered as well. Proper justification is provided in
Annex A – Clinical Evaluation Plan. Cadaver studies were considered too as detailed in c).
- The data must relate to the same patient population for which the device is intended, with the
exception of deviations mentioned above.
- The data must relate to similar devices. Devices considered to be equivalent will have similar
materials, specifications, properties, surface characteristics, design, deployment methods.
Systematic search outcomes and assessment of documents are detailed in the Literature Search
Report (Annex B).
In summary:
Evaluation of equivalence: the following devices have been found to be equivalent to the Oscar
device:
- Biomet Ultra-Drive 3
- Mectron Piezosurgery Medical/Flex/Plus (for the “bone cutting” intended use only)
- Misonix Ultrasonic BoneScalpel (for the “bone cutting” intended use only)
Proper search strings were built. Search strings comprised different keywords. More specifically,
these were either
- the name of the device (“Oscar” on one of the equivalent devices) alone, even considering
their most probable writing variants, or
- the device name/manufacturer AND the surgical application (for example: “Oscar” and
“arthroplasty revision”), or
- the device name/manufacturer AND the intended use (for example: “Oscar” and “cement
removal”), or
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 34 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
1. OSCAR
2. OSCAR II
3. OSCAR 3
4. BONECUTTER
5. ORTHOSONICS
6. REVISION ARTHROPLASTY
7. PROSTHESIS REVISION
8. CEMENT REMOVAL
9. BONE CEMENT REMOVAL
10. OSTEOTOME
11. BONE CUTTING
12. PIEZOSURGERY
13. ULTRASOUNDS
14. ULTRASONIC DEVICE
15. ULTRASOUND DEVICE
16. PIEZOELECTRIC
17. CADAVER
18. HIP REVISION
and retrieved the articles listed in the first tab of the Oscar_Literature_Search_Report.xlsx file
attached.
Each document/data identified was recorded and screened rapidly to determine if the article is of
any relevance: inclusion criteria/exclusion criteria were used for screening purposes. Each
document/data accepted was screened in more detail according to Index of the Origin, Index of
the Similarity and Index of the Quality reported in the P.O. 215. Any documents not meeting the
criteria was logged as inappropriate and excluded. Each document/data accepted was then
analyzed and relevant useable data was included in the clinical evaluation.
Articles in the green zone Articles in the yellow zone Articles in the red zone
N=12 N=18 N=0
+ 2 cadaver studies
The systematic search, the assessment of documents and the critical evaluation were performed
by a person suitably qualified in the research field, and reviewed and approved by an expert
knowledgeable in the “state of the art”. Evidence for these statements is attached in Annex C.
Declaration of interests is attached in Annex D.
Several testing and verification have been conducted on OSCAR 3 equipment for the verification of
safety and effectiveness.
Oscar 3 has two functionalities: cement remover and osteotomy; according to manufacturer
consideration and power input measures, the cement remover has been considered the worst case
during the tests.
The equipment is tested in intermitted operation mode (Ton=10 seconds, Toff=20 seconds) as per
the following clauses of the standard:
Clause 4.6 - ME Equipment or ME system parts that contact the patient –
Clause 4.8 - Component of ME equipment -
Clause 5.9.1 - Applied Parts –
Clause 6.4 - Method(s) of sterilization –
Clause 7 - ME equipment Identification, marking and documents –
Clause 7.2.12 - Fuses
Clause 9.6.3 - Hand transmitted vibration -
Clause 11.6.7 - Sterilization of ME EQUIPMENT and ME system -
Clause 11.7 - Biocompatibility -
Clause 12.2 - Usability -
Clause 14 – Programmable electrical Medical System (PEMS) -
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 37 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Additionally, Orthofix S.r.l guarantees the development and postproduction monitoring and
maintenance of software respecting all the requirements listed in the standard IEC 62304:2006.
In detail about the clause 6 (not previously included in IEC 60601-1 evaluation) Orthofix S.r.l has in
place in its Quality Management System specific procedures to properly manage the maintenance
of software post release.
The process is internally managed through an official request (internal procedure PG 600:
Registration of request; Preliminary evaluation; Identification of owner; Feasibility study;
Implementation of modification) that requires an evaluation and feasibility study of request.
In case of decision of implementation of modification, the development of SW modification is
managed with reference to internal procedures (PG 199 and PO 199) for which is required a
formalization of development plan in which all the activities, deliverables, verification and
validation necessary will be formalized.
Measurements have been done on handsets and applicators of Orthofix Oscar 3, in particular:
As regarding Orthofix OSCAR 3, all testing according to Clause 6.1 (Emissions) and 6.2 (Immunity)
have been conducted:
6.1 Emissions
6.1.1.2 Limits of mains terminal disturbance voltage
Limits for radiated disturbance
6.1.3.1 Harmonic current emissions
6.1.3.2 Voltage fluctuations and flickers
6.2 Immunity
6.2.2 Electrostatic discharges (ESD)
6.2.3 Radiated RF electromagnetic fields
6.2.4 Electrical fast transients and bursts
6.2.5 Surges
6.2.6 Conducted disturbances, induced by RF fields
6.2.7 Voltage dips, interruptions, and variations
6.2.8 Magnetic field
Biocompatibility
Since the raw materials and processes used to manufacture Oscar probes are equivalent to those
that are commonly used for titanium implants that have a long history of safe use in clinical
applications, and since the Oscar probes are meant instead only for a limited body contact, we may
conclude that no tests are necessary to demonstrate that they are unlikely to cause adverse
reaction after use.
Nevertheless, all the test suggested in Table A.1 of ISO 10993-1 for this category of devices were
taken into account and performed.
Initially, the structural properties have been determined via single cycle bend testing (Ref. 22300-
T02-03-RP, Section IV.a, DMF A.3.7). Once static load deflection data for the plates have been
gathered, M-N curves for the plates have been created based on fatigue test results. The curves
have been used to compare fatigue strength at different fatigue life levels (Ref. 22300-T03-01-RP,
Section IV.a, DMF A.3.7).
The plate with the smallest cross-sectional area was selected to be the worst case plate because it
presents the largest stress that the implants would undergo in a clinical setting. As described
previously, plate thickness, smallest moment of inertia (which considers cross-sectional geometry),
and plate length are the primary variables for comparing stress between the various plates.
Test summary and all test activities performed are detailed in Section IV of DMF A.4.1.
Data retrieved concerned safety and performance of the Oscar device, or of an equivalent device,
for both the applications of bone cement removal (references 1-13), and of bone cutting
(references 14-33).
Data were mostly derived from clinical studies (1-4, 8-33); however, as justified in Annex A,
2 cadaver studies were also included for safety considerations (6,7), as studies on heat transfer are
considered highly relevant being Oscar a piezo-electric, ultrasonic device involving transfer of heat
to the human body. Such studies can in fact only be performed on cadaver specimens for ethical
reasons, as patients would be exposed to unacceptable risks.
A report from the National Institute for Health and Care Excellence (NICE) was also
included in this evaluation as it provides specialist commentator observations on studies that
specifically assessed the performance and safety of the Oscar device (1-3). As it emerges from this
report and from Orthofix considerations, data only on the Oscar device (references 1-5) are
limited.
Thus, to assess data of sufficient quality and quantity, the literature evaluation included
studies on equivalent devices (references 6-33) that were used in orthopaedic applications
(references 1-13) as well in the fields of neurosurgery (14-21), Foot&Hand surgery (22),
craniofacial surgery (23,24), ENT surgery (25-33).
As also stated in Annex A, when osteotomies are performed in these fields (i.e. neuro-,
Foot&Hand, craniofacial, and ENT surgery), they involve operating in anatomic areas that are
intrinsically more at risk than those involved in orthopedics, as nerve structures are closer. If
devices equivalent to Oscar, having also an intended use for osteotomy in these additional fields,
were to be found safe and effective for these applications, safety and effectiveness of the Oscar
device for bone cutting in orthopedic surgeries would be proved all the more.
There is heterogeneity in the quality and type of study design of the clinical studies
included in this evaluation. The literature assessed comprised 5 case reports (1,3,9,22,31), 2 case
series (3,30), 11 retrospective studies (2,4,8,11,12,14,15,17,19-21), and 11 prospective studies
(10,18,23-29,32,33). One study (13) included clinical data collected both retrospectively and
prospectively.
Statistical analyses were conducted only in studies that included a relatively large number
of patients (2,11,14,19,25-29); in all studies probability values at less than 0.05 were regarded as
significant. Depending on the outcomes assessed, statistical analyses were undertaken, as
Overall, clinical studies assessed included a total of 2319 patients; of those, 1001 were
treated with either the Oscar device or with and equivalent device. The clinical studies included
both pediatric and adult patients, with extremes between 4 and 87 years, and both female and
male patients.
Even if prospective studies including a large cohort of patients treated with the Oscar
device are missing, overall data were of sufficient quality and quantity for allowing meaningful
assessment of the devices’ performance and safety.
Concerning the performance of the Oscar device or of equivalent devices, the papers
analyzed - when considered in the whole - outline a scenario that confirms that the device is safe
and performing for its intended use(s). Considering data retrieved in the whole, it can be stated
that no peculiar hazards emerge connected with the use of the device, with the main
complications being those already described in the clinical background in paragraph 4. The main
risk associated with the use of the device is thermal damage; this risk can be minimized by
adequate irrigation and surgical knowledge. These aspects are adequately addressed in the IFU of
the Oscar device.
In general, data retrieved show that the benefit deriving from the use of the piezoelectric
devices strongly outweighs the risks that they may carry.
A detailed analysis of the safety of the device under examination is provided in the next sections.
The table below summarizes the types of study included in this evaluation; for each study,
the number and characteristics of patients treated, and the post-operative follow-up period are
reported.
The articles full-texts are available in Annex B.
(1) Smith and Oscar Removal of a massive intrapelvic 1 1 83-year old woman. Case report N/A
Eyres, 1999 cement mass
(2) Fletcher et Oscar Cement removal in revision total hip 13 cases 16 (17 cases) 3 men, 13 women. Age: 62 to 87 years. Retrospective N/A
al., 2000 arthroplasties (Wagner prosthesis) case series
(3) Golberg et Oscar Cement removal from the humerus 1 1 Woman, 69-year-old. Note that the study also Case report 9 months
al., 2005 during revision arthoplasty included 6 human cadaveric specimens.
(4) Peach et Oscar Total elbow arthroplasty (TEA) 10 33 (34 cases) 23 women, 10 men. Mean age was 65 years Retrospective 52 months
al., 2013 revision (49 to 89). study (24 to
139).
(5) NICE, Oscar See references 1-3 See references 1-3 See See references 1-3. See See
2014 references 1-3 references 1-3 references
1-3
(6) Brooks et Biomet Ultra- Bone cement removal and bone Cadaver study on a See column N/A Cadaver study N/A
al., 1995 drive cutting certain number of on the left.
15 cm lengths of
human cadaver
femora.
(7) Brooks et Biomet Ultra- Bone cement removal. Cadaver study on See column N/A Cadaver study N/A
al., 1993 drive six 10 cm-long on the left.
sections of human
cadaver femora.
(8) Klapper et Biomet Ultra- Bone cement removal in revision hip 20 20 16 women and 4 men with hip prosthesis. Retrospective N/A
al., 1992 drive arthroplasty study
(9) de Steiger Biomet Ultra- Cement removal in hip arthroplasty 1 1 One male patient with hip prosthesis requiring Case report 2 months
et al., 1996 drive revision revision. Age:33.
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 43 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
(10) Haddad Biomet Ultra- Cement removal in revision hip 50 50 The patients were 27 women and 23 men with Prospective 5.8 years
et al., 2000 drive arthroplasty for infection a mean age of 60 years (24 to 81). study (2-8.7)
(11) Sneftrup Biomet Ultra- Bone cement removal in elbow 5 23 15 women and 8 men, with a median age of 62 Retrospective 55
et al., 2006 drive arthroplasty revision years (42 to 80) at the time of revision. study months
(15-97)
(12) Van Biomet Ultra- Cement removal during revision 23 23 Average age at revision was 69 years range, Retrospective 40.9
Thiel et al., drive shoulder arthroplasty. 52-81 years. study months
2011 (24-98)
(13) van Biomet Ultra- Cement removal in revision hip 136 136 63 female and 73 male, 64.4 ± 10.8 years. Retrospective 8.3 years
Diemen, 2013 drive arthroplasty +Prospective (2-15
data years)
assessment
(14) Bydon et Misonix Bone cutting in patients requiring 88 337 Of the 337 patients, 187 were male, and the Retrospective N/A
al., 2013 Ultrasonic posterior decompression of the mean age was 60.4 ± 16.2 years. In the study
BoneScalpel cervical or thoracic spine BoneScalpel treatment group, 49 patients
(55.7%) were male.
(15) Hu et al., Misonix Bone cutting in spine surgery 128 128 73 female, 55 male. The mean age of the Retrospective N/A
2013 Ultrasonic patients was 58 years (range 12–85 years). study
BoneScalpel
(16) Nickele Misonix Osteotomy for laminoplasty for either 5 5 N/A Case series N/A
et al., 2013 Ultrasonic tumor resection or DREZ lesion.
BoneScalpel
(17) Parker et Misonix Osteoplastic laminoplasty in the 40 40 29 adult and 11 pediatric patients. Sex: 20 male Retrospective Mean, 193
al., 2013 Ultrasonic resection of intradural spinal and 20 female. Mean age, 38.0 years; range, study days;
BoneScalpel pathology 4.0-79.7 years. median,
142 days.
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 44 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
(18) Al- Misonix Bone cutting in spinal surgey 62 937 Of the 62 patients treated with Bone scalpel: Prospective N/A
Mahfoudh et Ultrasonic 22 cases of primary lumbar laminectomy; 8 of study
al., 2014 BoneScalpel primary lumbar foraminotomies; 9 of revision
lumbar laminectomy; 4 cases of revision
lumbar foraminotomy/discectomy; 5 cases of
Facetectomies in association with
Transforaminal Lumbar Interbody Fusions
(TLIF); 7 cases of laminoplasty; 2 cases of
cervical corpectomy; 1 trench thoracic
vertebrectomy for excision of a calcified
thoracic disc; 2 cases of laminectomy for
access to intradural tumours (1 thoracic and 1
cervical); 2 cases of posterior cervical
foraminotomy.
(19) Bydon et Misonix Spinal Decompression in 10 30 Paediatric patients. In the BoneScalpel group, Retrospective 20.70±6.8
al., 2014 Ultrasonic Achondroplastic Patients mean age was 14.10±5.63 years. comparative 5 months
BoneScalpel study
(20) Misonix Ultrasonic total uncinectomy for 38 38 Mean age was 65 years (range, 43-80 years). Retrospective 28± 7
Pakzaban, Ultrasonic anterior decompression of cervical There were 17 men and 21 women. study weeks
2010 BoneScalpel nerve roots (14-37)
(21) Al- Misonix Management of Giant Calcified 29 29 Patients had herniated thoracic disk with pain Retrospective 19.8
Mahfoudh et Ultrasonic Thoracic Disks and paresthesia, weakness, thoracic back pain. study months
al., 2016 BoneScalpel 18 patients with giant calcified thoracic disks. (7months
Sex: 13 female, 16 male. The median age at to 2 years)
diagnosis was 51.2 years (range 37 to 70).
(22) Hoigne Mectron Correctional osteotomy of the 5th 1 1 23 years old, male. Case report 1 year
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 45 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Grauvogel et Piezosurgery acoustic neuroma surgery had acoustic neuroma. case series
al., 2011
(31) Heredero Mectron Spheno-orbital meningioma resection 1 1 52-years old woman. Case report 12 months
Jung et al., Piezosurgery
2011
(32) Mancini Mectron Endoscopic sinus surgery. 4 4 2 male and 2 female patients; mean age was Prospective 9 months
et al., 2012 Piezosurgery 55 years (48-63 years). case series
(33) Mectron Removal of retrovertebral body 9 9 5 female and 4 male; mean age in the patient Prospective Mean: 10
Grauvogel et Piezosurgery osteophytes in anterior cervical group was 58 years. case series months
al., 2014 discectomy
Complications/negative outcomes
- none
Other comments:
- this paper highlights the versatility of the Ultra-Drive device achieved thanks to the
wide range of tips available
1) The first stage of the surgery consisted of excision of sinuses and removal of
foreign and potentially infected material: cement, plugs and any potentially infected
soft tissue. Both femoral and acetabular implant sites were reamed thoroughly and
washed.
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 55 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
The use of Ultradrive at the first stage of the procedure in order to remove the cement was
successful.
Complications/negative outcomes
At a mean follow-up of 5.8 years a satisfactory clinical and radiological outcome was
obtained in all except two patients. The rate of reinfection was 8% (4 patients). Two of these
patients have had another, successful, two-stage revision. Prolonged immobilisation may
well have contributed to the early postoperative complications. These included cardiac
failure (2 cases), pulmonary embolism (1 cases), haematemesis (2 cases), infection of the
urinary tract (9 cases), palsy of the common peroneal nerve (1 case) which recovered, and
four dislocations managed by closed manipulation.
Other comments:
No complication was device-related.
11 Sneftrup, SB; Jensen, SL; Johannsen, HV; Søjbjerg, JO. Revision of failed total elbow
arthroplasty with use of a linked implant. J Bone Joint Surg Br. 2006;88(1):78-83.
The study describes the results of a retrospective study involving 23 patients who had been
subjected to total elbow arthroplasty and needed arthroplasty revision. The indication for
the primary elbow replacement was rheumatoid arthritis (16 patients), a fracture of the
distal humerus (4), post-traumatic osteoarthritis (3), and primary osteoarthritis (1). The
main indication for revision was aseptic Loosening (15 elbows). Other reasons included
periprosthetic fractures (6 elbows and 5 patients), instability (1) and deep infection (2). The
mean interval between the primary arthroplasty and the revision was 75 months (1 to 241).
During surgery both components of the arthroplasty were replaced with a linked Conrad-
Morrey implant. Bone cement was removed using the Biomet Ultra-drive device in 5 cases.
The five-year survival of the prosthesis was 83.1% (95%). confidence interval (CI) 61.1 to
93.3). The survival rate of the procedure described in this study resulted acceptable. On the
basis of the Mayo Elbow Performance Score the subjective, objective and functional
Ultrasonic curette tears tended to be more linear in quality with respect to traditional high-
speed drill. The device showed to be at least as safe and efficacious as the conventional high-
speed drill.
Complications/negative outcomes
5.7% of patients treated using an ultrasonic bone curette and 3.6% of patients treated using
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 60 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Other comments:
Curette tears tended to be more linear in quality with respect to traditional high-speed drill
and to be lateral in location and craniocaudal in orientation too.
15 Hu, X; Ohnmeiss, DD; Lieberman, IH. Use of an ultrasonic osteotome device in spine surgery:
experience from the first 128 patients. Eur Spine J. 2013;22(12):2845-9.
This work describes the results of a retrospective assessment of data concerning 128
patients who underwent several types of osteotomy: facetectomy, laminotomy,
laminectomy, en bloc resection, Smith Petersen osteotomy, pedicle subtraction
Osteotomy. In all cases, the ultrasonic Misonix BoneScalpel was used to create the needed
osteotomies to facilitate the surgical procedure without any percussion on the spinal
column or injury to the underlying nerves. The ultrasonic scalpel was used at all levels of
the spine and the average levels operated on each patient were 5. 11 instances of dural
injuries (8.6 %) were experienced.
Complications/negative outcomes
A total of 11 dural injuries (8.6 %) occurred in this case series. Since majority of the patients
had previous spine surgery and/or spinal deformity, this dural injury rate is comparable with
previous reports. Of these 11 cases, only 2 cases of dural injuries directly associated with the
use of ultrasonic device. The first case was a 3 mm dural thermal injury which resulted from
the overheating of the local tissue by the scalpel blade sitting in one position. This was over
sewn with a watertight closure. The second dural injury occurred in a revision case where
the dura was adherent and partially ossified. As the osteotomy was created and the bone
peeled off, the dura was torn in the lateral recess of the epidural canal. This was repaired
primarily with a dural patch. However, the patient developed positional headaches, nausea
and vomiting postoperatively. A MRI scan at 1 month postoperative showed a large complex
fluid collection in the posterior paraspinal soft tissues. The patient underwent a revision
surgery to repair the pesudomeningocele and she recovered well from the revision surgery
Other comments:
no follow up is provided
16 Nickele, C; Hanna, A; Baskaya, MK. Osteotomy for laminoplasty without soft tissue
penetration, performed using a harmonic bone scalpel: instrumentation and technique. J
Neurol Surg A Cent Eur Neurosurg. 2013;74(3):183-6.
The publication describes five cases in which the Misonix BoneScalpel was used to perform a
laminoplasty for various pathologies were: one cervical intramedullary tumor, one thoracic
intramedullary spinal mass, one lumbar extramedullary intradural tumor, and two cases of
multiple lower brachial plexus nerve root avulsions requiring dorsal root entry zone (DREZ)
lesion. All patients underwent similar surgery procedure. After proper preparation and
preliminary surgical steps, the Misonix BoneScalpel was used to perform a continuous cut
through the laminae of vertebra, on both sides. Motor evoked potentials (MEPs) and
somatosensory evoked potentials (SSEP) were used for the procedure, and there were no
changes in these monitoring modalities during laminotomy. Duraplasty was then performed
with a dural substitute, and bone was replaced in situ and secured with plates. SSEP and
MEP monitoring were not affected by the use of the bone scalpel during the laminoplasty.
Complications/negative outcomes
- the aerosol generated by the device did not allow to properly visualize the dura
Other comments:
- additional irrigation was used to supplement the built-in one as authors were highly
concerned of overheating
17 Parker, SL; Kretzer, RM; Recinos, PF; Molina, CA; Wolinsky, JP; Jallo, GI; Recinos, VR.
Ultrasonic BoneScalpel for osteoplastic laminoplasty in the resection of intradural spinal
pathology: case series and technical note. Neurosurgery. 2013;73(1 Suppl Operative):ons61-
6.
In this study there was a 2.5% durotomy rate with the use of the ultrasonic osteotome in this
series. In comparison, our institution previously reported a durotomy rate of 4.3% with the
use of the high-speed drill, traditional technology, in a trial based on spinal fusion.
BoneScalpel showed to be a safe and technically feasible device for performing osteoplastic
laminoplasty.
Complications/negative outcomes
1 case of cerebrospinal fluid
leak, 1 case of seroma. The cerebrospinal fluid leak developed 2 weeks postoperatively and
was managed successfully by oversewing the wound in the outpatient setting. The epidural
seroma required operative evacuation, and the laminoplasty bone was removed because of
the possibility of infection at the time of surgery. 1 case (2.5%) of incidental durotomy after
osteoplastic laminotomy. It resulted in no neurological injury and was repaired primarily
without subsequent cerebrospinal fluid leakage. This occurred during the user’s first
experience with the device and was visualized as a linear heat-related defect likely caused
by excessive downward pressure after the inner laminar cortex had been cut.
Other comments:
Of the 40 cases, 11 were pediatric patients.
18 Al-Mahfoudh, R; Qattan, E; Ellenbogen, JR; Wilby, M; Barrett, C; Pigott, T. Applications of the
ultrasonic bone cutter in spinal surgery--our preliminary experience. Br J Neurosurg.
2014;28(1):56-60.
This study describes results of a prospective collection of data concerning 937 patients
undergoing spinal surgery. For 62 of them, surgery was performed with the aid of the
Misonix Bone Scalpel ultrasonic bone cutter; there were 22 cases of primary lumbar
laminectomy, 8 of primary lumbar foraminotomies, 9 of revision lumbar laminectomy, 4
cases of revision lumbar foraminotomy/discectomy, 5 cases of facetectomies in association
with Transforaminal Lumbar Interbody Fusions (TLIF), 7 cases of laminoplasty (4 cervical, 2
thoracic and 1 lumbar), 2 cases of cervical corpectomy, 1 trench thoracic vertebrectomy for
excision of a calcified thoracic disc, 2 cases of laminectomy for access to intradural tumours
(1 thoracic and 1 cervical) and 2 cases of posterior cervical foraminotomy. Complications
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 63 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Complications/negative outcomes
- complications (total rate being 17.7%) were as follows:
Related to the Misonix Bone Scalpel:
- one dural lesion (1.6%)
Unrelated to the Misonix Bone Scalpel:
- one case of blood loss greater than 500 ml (1.6%),
- three iatrogenic dural lesions (4.8 %),
- two wound infections (3.2%),
- two cases where worsening of neurology was observed,
- one patient undergoing laminoplasty suffered a C5 root lesion.
19 Bydon, M; Macki, M; Xu, R; Ain, MC; Ahn, ES; Jallo, GI. Spinal decompression in
achondroplastic patients using high-speed drill versus ultrasonic bone curette: technical note
and outcomes in 30 cases. J Pediatr Orthop. 2014;34(8):780-6.
In the Bone Scalpel group, the device was responsible for only one of the durotomies, the
remaining two being caused by other surgical instruments.
Other comments:
Complications/negative outcomes
- Complications were 1 wound erythema (2.6%), 3 transient cases of mild hoarseness
(7.9%) and 2 cases of dysphagia after 6 weeks (5.2%).
- These minor complications were similar to those experienced with standard ACDF
- None of them was related to the use of the ultrasonic device
Other comments:
additional irrigation was used to supplement the built-in one as authors were highly
concerned of overheating
21 Al-Mahfoudh, R; Mitchell, PS; Wilby, M; Crooks, D; Barrett, C; Pillay, R; Pigott, T.
Management of Giant Calcified Thoracic Disks and Description of the Trench Vertebrectomy
Technique. Global Spine J. 2016;6(6):584-91.
In this case series, 29 cases of herniated thoracic disk with pain and paresthesia, weakness,
thoracic back pain are described. Of these 29 cases, 18 patients had giant calcified thoracic
disks,ndefined as diffusely calcified disks occupying at least 40% of the spinal canal, requiring
special neurosurgical consideration owing to significant involvement of the spinal canal and
compression of the spinal cord, often leading to myelopathy. Of the 18 cases of giant
calcified thoracic disks, Thoracotomy was performed on 17 (94.4%) patients, and 1 (5.6%)
patient had a costotransverse approach. A trench vertebrectomy was performed with half of
vertebra on either side excised. The ultrasonic bone cutter was useful here as an alternative
to piecemeal resection or using a pneumatic drill. Although GCTDs (Giant Calcified Thoracic
Disks) are difficult neurosurgical challenges, excellent fusion rates were achieved in this case
series with insertion of rib head autograft in the trench with the help of the ultrasonic bone
cutter.
Positive clinical results/positive outcomes
Fifteen (83.3%) patients experienced a postoperative improvement of at least 1 point in the
mJOA (Japanese Orthopaedic Association) score on last follow-up. The remaining three
patients’ mJOA scores remained at least unchanged. These results are encouraging. There
was no surgical mortality and none of the patients experienced neurologic decline.
Complications/negative outcomes
Postoperative complications included cerebrospinal fluid leak in 2 patients (11.1%). This
complication was identified and repaired intraoperatively with no further sequelae. Six
(33.3%) patients required a blood transfusion during their hospital stay. One (5.6%) patient
was transferred to the intensive care unit for ventilatory support due to development of
Other comments:
The complications were not device-related.
About Mectron Piezosurgery
22 Hoigne, DJ; Stübinger, S; Von Kaenel, O; Shamdasani, S; Hasenboehler, P. Piezoelectric
osteotomy in hand surgery: first experiences with a new technique. BMC Musculoskelet
Disord. 2006;7():36.
This reference reports the case of 23-years old man who presented with a malunited
metacarpal bone fracture of the fifth finger on his dominant hand, causing a 45 degree
angular deformity of the fifth metacarpal neck with internal rotation. A treatment plan was
designed calling for a correctional osteotomy of the 5th metacarpal bone. A longitudinal
incision was made over the fifth metacarpal. The tendon of the extensor digiti minimi was
found and on its radial side the periosteum of metacarpal five was reached. The periosteum
was opened longitudinally over the defect as usual. For the correction of the defect of 45
degrees, a bone wedge was excised. Instead of using the traditional oscillating saw, the
Piezosurgery Devicewas used. A sharp hardened saw coated with titannitrid was used at the
higher power level with automatic irrigation cooling at its maximum level. Angulation and
rotation were corrected and bone extremities fixed with a 1.5 mm titanium five-hole plate
and four screws. Closure of the wound was done in layers. Mobilization was started on the
10th postoperative day. The postoperative healing of the wound and the bone consolidation
were smooth and recovery shorter than what is usually observed in these cases. The patient
regained full use of his finger according to the state before the fracture. 12 months after
results were still satisfactory.
Complications/negative outcomes
- none along the 12-month follow-up period
Other comments:
- authors stress the need for continuous and intense irrigation of the osteotomy site.
24 Gleizal, A; Bera, JC; Lavandier, B; Beziat, JL. Piezoelectric osteotomy: a new technique for
bone surgery-advantages in craniofacial surgery. Childs Nerv Syst. 2007;23(5):509-13.
This non-randomized, prospective clinical trial describes the use of the Piezosurgery device in
different craniofacial surgical procedures. Patients distribution was as follows: a) 30 cases of
craniofaciostenosis (15 trigonocephaly, 15 plagiocephaly) requiring superior orbital removal;
b) 2 patients with Crouzon syndrome requiring Le Fort III osteotomy; c) 30 cases of
craniofaciostenosis (trigonocephaly and plagiocephaly), requiring parietal and frontal bone
cut. The median age was 6.2 months for the group of craniostenostosis treated with the
piezoelectric device and 6.4 months for the mechanical group. The ultrasonic device was 1.
to remove the superior orbital roof in cases of craniofaciostenosis, 2. to perform the Le Fort
III osteotomy on the two patients affected by the Crouzon syndrome in two patients, 3. to
cut the parietal and frontal bone in cases of craniofaciostenosis. Different types of
information were collected including: 1. the duration of time for each bone cut (this does not
include the repair of the dura tear, in case of dura mater injuries), 2. the absence of injury to
the dura mater and globe after the removal of the roof or external wall of the orbit, 3. the
absence of injury to the dura mater and brain tissues after the removal of the parietal and
frontal bone cutting. All results were compared to those observed in cases using mechanical
bone sectioning (15 trigonocephaly, 15 plagiocephaly, 2 Le Fort III osteotomies, 20 cases of
parietal unicortical bone graft). Functional results were good without any soft tissue damage
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 69 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Complications/negative outcomes
- Intermittent otorrhea with perforation of the tympanic membrane occurred in one
patient (3%) in the Piezosurgery group and 3 patients (10%) in the microdrill group.
- The complication in the Piezosurgery group was not related to the use of the device.
Other comments:
- none
29 Crippa, B; Salzano, FA; Mora, R; Dellepiane, M; Salami, A; Guastini, L. Comparison of
postoperative pain: piezoelectric device versus microdrill. Eur Arch Otorhinolaryngol.
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 73 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Complications/negative outcomes
None along the 9-month follow-up
Other comments:
None
33 Grauvogel, J; Scheiwe, C; Kaminsky, J. Use of Piezosurgery for removal of retrovertebral body
osteophytes in anterior cervical discectomy. Spine J. 2014;14(4):628-36.
This prospective clinical study describes the treatment of 9 patients (five female and four
male) with symptoms of either cervical radiculopathy or cervical myelopathy resulting from
soft or hard disc herniation and retrospondylar osteophytes causing spinal nerve or spinal
cord compression. Protocols of anterior cervical discectomy with fusion (ACDF) surgery were
The angled inserts were effective in cutting bone spurs behind the adjacent vertebra which
cannot be reached with conventional rotating burs. There were no postoperative
complications such as hoarseness, hematoma, infection, or cerebrospinal fluid fistula in our
patient group. Postoperative radiographs of the cervical spine also showed no complications
at the site of the implant.
Complications/negative outcomes
A slightly prolonged operation time was observed for Piezosurgery. Furthermore, the design
of the handpiece could be further improved to facilitate the intraoperative handling in ACDF.
Other comments
In this study two Mectron devices were used. In the first seven cases, a device called
Piezosurgery II, and in the other two cases a more sophisticated device, the Piezosurgery
medical were used. The more powerful Piezosurgery medical device was specially
constructed for neurosurgical and orthopedic use, whereas the Piezosurgery II device was
originally designed for use in dental and maxillofacial surgery. Both instruments showed to
be safe and effective.
When the Oscar device was used for bone cement removal, the only complication observed was
related to overheating, as described by Goldberg, 2005 (3). Goldberg investigated the matter more
in depth, through a cadaver study, again described in (3), observing how overheating was strictly
dependent by the presence or absence of irrigation, with irrigation effectively decreasing heating
into acceptable ranges. Brooks et al., (1993) (7) again observed in cadaver studies that heating
may be effectively reduced by proper irrigation. Ultrasonic devices seem to be quite easy to
handle, as only once a complication was observed because of improper connection of the tool to
the handpiece as described in de Steiger et al., 1996 (9). Other device-related complications are
quite scarce. The study of van-Diemen et al. (13), for example, describes a routine use of an
equivalent device in removing bone cement during resection arthroplasty, on 136 patients, not
provide any specific feedback as bone cement removal was just an intermediate step of surgery.
This may implicitly imply that the device did not cause any intra-operative complications. No post-
operative device related complications were observed in the same study. When equivalent devices
were used for bone cutting, in other fields than Orthopaedics, the rate of general complications
was in all cases within the same range of that observed when non-ultrasonic instruments were
applied. Studies on ear surgery – where auditory nerves are strictly close to bone subjected to
osteotomy, confirm indirectly that, with proper irrigation, no overheating and consequent damage
is observed as the patient’s audiologic functional parameters don’t suffer any significant decrease.
In general, all authors stress the importance of constant and abundant irrigation. In Neurosurgery,
the only rare complications observed were dural perforations, whose rate (<10%) was within the
range observed with non-ultrasonic instruments.
A description of the study methods and results and a list of all complications observed in the
studies, including the ones that were not related to the use of the piezoelectric instruments, are
available in Annex I. The table below provides the list only of complications that were related to
the use of the medical devices.
All the complications that have been reported in the clinical data assessed that concerned
orthopaedic applications are adequately addressed in the device IFU (see table below).
In conclusion, there is consistency between current knowledge, the available clinical data, the information materials supplied by the
manufacturer, and the risk management documentation for the device.
According to our clinical evaluation, the requirement of safety of the Oscar device is satisfied.
An in-depth analysis of the identified hazards and benefits reported in the studies analyzed is
provided in Annex I.
As outlined in the preceding Section, the only serious adverse event observed was necrosis
of muscle, cortical bone and nerve tissue, probably due to overheating, provoking both a radial
nerve palsy and indirectly a pathologic humeral fracture in a patient. The risk of thermal damage
can be considered acceptable in lights of the several benefits associated with the use of the device
(see below) and of the fact that this type of hazard can be prevented using adequate surgical
knowledge and irrigation during the procedure.
Overall, the use of the Oscar device or of an equivalent piezoelectric instrument provided
definite benefits: the instruments allowed for precise and safe bone cutting and bone cement
removal. The use of the ultrasound technology allowed to minimize damage to bone and soft
tissues, to preserve bone stock, and to reduce bleeding, thus improving intraoperative visibility.
The authors also report describe good user manageability. The benefits described by the authors
of the studies are as follow:
Reference Device Benefits associated with the use of the piezoelectric device
(1) Smith Oscar Cement removal is atraumatic. The risk of plunging into the pelvis with a sharp instrument is
and Eyres, minimized. Damage to surrounding bone was avoided.
1999 Access to the cement was simple because the probes are thin and can be manoeuvred in
small spaces without difficulty.
Cement is an effective thermal insulator, and the controlled use of an ultrasonic tool in close
proximity to major organs is safe in respect to potential thermal injury.
Time-effective.
(2) Fletcher Oscar Oscar permitted easy removal of distal cement.
et al., 2000 The time needed to remove bone cement did not exceed 15 minutes; in several cases
cement removal was accomplished in less than five minutes.
The use of the Oscar device was significant in preserving bone stock by reducing the length
of the osteotomy.
It permitted the use of a shorter prosthesis in 60% of cases.
The warning signal incorporated within the system makes inadvertent penetration less likely
and thus may have contributed to the lack of perforations or cortical breaches.
(5) NICE, Oscar Specialist commentator comments:
2014 protect the bone by avoiding perforation or fracture.
Speed up the procedure.
Reduces the need for osteotomies.
Allows for use of shorter femoral prostheses, thus preserving distal femoral bone.
(6) Brooks et Biomet Ultra- Low risk of perforation
al., 1995 drive
(8) Klapper Biomet Ultra- Facile distal plug removal.
et al., 1992 drive Preserve proximal bone stock.
No cortical perforations.
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 82 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Analysis of complaints:
Orthofix complaints from the market are managed by Orthofix Quality Assurance & Regulatory
Dept, using the specific computerised software Qbase since 2001 July. This system allows to
constantly monitor the trend of problems reported with Orthofix devices and to trace returned
products by product code, lot number, manufacturing date, cause, etc. Orthofix conducts an
investigation on all devices returned from the market and provides customers with its failure
analysis results.
From 2017 to date 126 complaints involving Oscar have been analysed and closed. The complaints
have been summarized as follows:
REPORTED TO CA
ADVERSE
CAUSE ANALYSIS
EFFECTS
Incorrect handling NO N
Production problem NO N
Device performed properly NO N
Normal wear and tear NO N
Incorrect use NO N
Oscar and equivalent devices were effective for bone cement removal in different revision
surgeries, and specifically revisions of hip (1,2,8,9,13), elbow (4,11), and shoulder (12)
arthroplasty. The authors observe a series of advantages related to the use of Oscar or equivalent
devices in removing bone cement. The piezoelectric action prevents the vibrating tip to damage
soft tissues because of the high frequency used. This feature was exploited by Smith et al. (1) to
access bone cement through the original first hip arthroplasty access even in a delicate situation
where damage to major structures, as cement was protruding into the pelvis, could have occurred
and a retroperitoneal access would have been the alternative option. Further, effective cement
removal using the Oscar device allowed Fletcher et al. (2) to shorten the length of osteotomy in
the transfemoral approach to remove the femoral stem during hip arthroplasty, sparing a
significant amount of bone stock and allowing them, in >50% of cases, to implant a shorter
prosthesis than in the traditional approach. Comments in the NICE reports by NICE experts are
consistent with these observations: all agree that using Oscar/an equivalent device may reduce the
need of performing large osteotomies, and the risk of cortical perforation. The claim of a low risk
of cortical perforation is supported by the cadaver study of Brooks et al. (6) who showed that even
when a 1-mm thick cortical layer is involved, the loads to apply to observe fracture are significantly
greater than those normally used to remove cement.
Concerning bone cutting, literature retrieved shows that an ultrasonic scalpel like Oscar can
be used effectively in a number of applications involving osteotomies that are not limited to
Orthopaedics (the intended field of application of Oscar) but extend to other fields, such as
Neurosurgery, ENT and Foot&Hand surgery. Devices equivalent to Oscar are routinely applied
effectively to perform spinal decompression for extradural pathologies (Bydon et al., 2013 (14);
Bydon et al., 2014 (19); Pakzaban, 2014 (20)) ore vertebral osteoplasty during discectomy
(Grauvogel et al., 2014 (33)); in spine surgery (Hu X et al., 2013(15); Nickele C et al., 2013 (16);
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 90 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Thus, the performance of the Oscar device, or of an equivalent medical device, was satisfactory for
both bone cement removal and bone cutting.
As highlighted in the previous paragraph concerning the Summary of clinical data and Summary of
conformity assessment with requirement on safety, data is of sufficient amount and quality to
allow detecting the undesirable effects connected with the use of the device. The rate of adverse
events associated with the use of the device was extremely low; those related directly to the
application of the device in the orthopedic field thermal injury (3) and bone perforation caused by
misuse of the device (wrong assembly) (9).
To our opinion, no gaps or unanswered questions remain concerning the side effects and their
acceptability. Side effects, as already outlined, may be regarded as definitively acceptable at the
light of the benefits deriving from the use of the piezoelectric instruments.
Summary about data supporting the essential requirements and the performance
claims
Overall, the clinical data retrieved showed that the use of the Oscar device, or of an equivalent
device, was safe and effective and all the relevant MDD ERs are supported by the clinical data
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 91 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
Claim Reference
Efficient Piezoelectric devices allow to reduce the need to use manual
performance: instruments, allowing for a controlled surgical experience and increased
designed to reduce precision (20;23;25;30) (see Table in Section 10, Summary of conformity
manual force assessment with requirement on acceptable benefit/risk profile (MDD
ER1 / AIMDD ER1).
The performance is In all articles retrieved, the device achieved the expected performance,
reproducible allowing the surgeons to make precise cut or remove bone cement.
The equipment is The authors of several articles (1; 8;22;25;26;27;28;30) directly support
simple to operate. that the equipment was simple to operate and handle. (see Table in
Section 10, Summary of conformity assessment with requirement on
acceptable benefit/risk profile (MDD ER1 / AIMDD ER1).
Versatile: single use The device is versatile by virtue of its design thought to make Oscar
probes for both practical for both the bone cutting and bone cement removal
cement and applications. Several single use probes with different sizes and shapes are
prosthesis removal. available; Oscar was in fact used in different anatomic regions, including
pelvis, hip, humerus, and elbow.
A specific comment on the probe design was made by Hoigne et al. (22):
“The tip of the instrument is exchangeable. Using the fine tip enables
multiplanar as well as curved cutting”.
A concern regarding the design of the handpiece was raised by Grauvogel
et al. (30) who reported that a longer and thinner
handpiece or a bayonet-shaped design of the handpiece
would considerably facilitate the procedure. The limits of the design were
however strictly linked to the type of surgery performed, i.e., neuroma
surgery, and the need to handle the device in the narrow space of the
human cerebellopontine angle. The author stated that this becomes a
minor problem with increasing expertise. No concerns were raised in the
articles dealing with the orthopedic field.
Safe: designed to The use of the piezoelectric device minimizes the risk of damage to bone
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 92 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
The risks associated to each hazard were carefully estimated and their acceptability was
demonstrated by compliance with available information. No other hazards were generated by the
risk reduction procedure. The remaining risks associated with the identified hazards are
acceptable, having regard to the intended application and use of the device, the risk/benefit ratio
and Orthofix’s Policy for Determining Acceptable Risk (PG208-01) (Ref. Sect. III.b DMF C.1.1-C Risk
Analysis).
12. CONCLUSIONS
On the basis of the clinical data retrieved in literature and on their analysis, the benefits to health
deriving from the use of the Oscar device, as intended by the manufacturer, outweigh the risks of
injury deriving from such use. As it was shown in the paragraphs that precedes, the benefits to
health deriving from the use of the device consist, summarizing, in precise bone cutting/bone
cement removal which is safe for bone as well as soft tissues. The complication rate is extremely
low, yet the device should be used in surgical procedures that must be performed by skilled
surgeons in order to prevent the risk of thermal damage or other injuries caused by misuse of the
device. Provided these conditions are met, as appropriately highlighted in the informative material
that Orthofix provides to the users, the benefit/risk profile of the Oscar device is fully acceptable.
On the basis of the data retrieved, the objectives of the literature review have been met; the risks
identified in the risk analysis document relating to safety and performance have been addressed
by clinical data.
It can be concluded
• that the clinical evaluation demonstrates that any risks which may be associated with the
intended purpose are minimised and acceptable when weighed against the benefits to the patient
and are compatible with a high level of protection of health and safety; and
• that the IFU correctly describe the intended purpose of the device as supported by sufficient
clinical evidence; and
• that the IFU contain correct information to reduce the risk of use error, information on
When used under the conditions and the purposes intended by the manufacturer the device is in
compliance with:
During the risks analysis sessions, the following clinical aspects have been identified as topic of future
evaluations:
13. POST MARKET SURVEILLANCE ACTIVITIES AND DATE OF THE NEXT CLINICAL
EVALUATION
Orthofix Srl, the manufacturer of the device, is responsible worldwide for the post market
surveillance.
Orthofix Srl has established documented procedures, which describe the requirements, criteria,
activities and relevant responsibilities for the management of post market surveillance activities,
including product complaints and medical device reporting activities (Annex E).
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 96 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
14. REFERENCES
1 Smith, PN; Eyres, KS. Safe removal of massive intrapelvic cement using ultrasonic
instruments. J Arthroplasty. 1999;14(2):235-8.
2 Fletcher, M; Jennings, GJ; Warren, PJ. Ultrasonically driven instruments in the transfemoral
approach--an aid to preservation of bone stock and reduction of implant length. Arch
Orthop Trauma Surg. 2000;120(10):559-61.
3 Goldberg, SH; Cohen, MS; Young, M; Bradnock, B. Thermal tissue damage caused by
ultrasonic cement removal from the humerus. J Bone Joint Surg Am. 2005;87(3):583-91.
4 Peach, CA; Nicoletti, S; Lawrence, TM; Stanley, D. Two-stage revision for the treatment of
the infected total elbow arthroplasty. Bone Joint J. 2013;95-B(12):1681-6.
5 NICE - The National Institute for Health and Care Excellence. The OSCAR 3 ultrasonic
arthroplasty revision instrument for removing bone cement during prosthetic joint
revision. Published: 19 November 2014
6 Brooks, AT; Nelson, CL; Hofmann, OE. Minimal femoral cortical thickness necessary to
prevent perforation by ultrasonic tools in joint revision surgery. J Arthroplasty.
1995;10(3):359-62.
7 Brooks, AT; Nelson, CL; Stewart, CL; Skinner, RA; Siems, ML. Effect of an ultrasonic device
on temperatures generated in bone and on bone-cement structure. J Arthroplasty.
1993;8(4):413-8.
8 Klapper, RC; Caillouette, JT; Callaghan, JJ; Hozack, WJ. Ultrasonic technology in revision
joint arthroplasty. Clin Orthop Relat Res. 1992;(285):147-54.
9 de Steiger, RN; Pandey, R; McLardy-Smith, P. Ultrasonically driven tools. J Arthroplasty.
1996;11(1):120-1.
10 Haddad, FS; Muirhead-Allwood, SK; Manktelow, AR; Bacarese-Hamilton, I. Two-stage
uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br.
2000;82(5):689-94.
11 Sneftrup, SB; Jensen, SL; Johannsen, HV; Søjbjerg, JO. Revision of failed total elbow
arthroplasty with use of a linked implant. J Bone Joint Surg Br. 2006;88(1):78-83.
12 Van Thiel, GS; Halloran, JP; Twigg, S; Romeo, AA; Nicholson, GP. The vertical humeral
osteotomy for stem removal in revision shoulder arthroplasty: results and technique. J
Shoulder Elbow Surg. 2011;20(8):1248-54.
13 van Diemen, MP; Colen, S; Dalemans, AA; Stuyck, J; Mulier, M. Two-stage revision of an
infected total hip arthroplasty: a follow-up of 136 patients. Hip Int. 2013;23(5):445-50.
Orthofix Srl - Via delle Nazioni, 9 37012- Bussolengo (VR)
Tel 045 6719000 Fax 045 6719380
Page 97 of 100
PO 215 Ed. 07 REF. CER_Oscar3_ C.1.1_Rev. 2
16. ANNEXES